Review Article

A Meta-Analysis of Adalimumab for Fistula in Crohn’s Disease

Table 3

Partial response rate of ADA treatment on CD and fistula.

TrialsTherapy weeksPartial response rate

Hinojosa et al. [16]4 w41%
Dewint et al. [15]24 w47%
Castaño-Milla et al. [12]12 m8%